1 unchanged sentence
Securities Market Information
−Removed: Our common stock has been listed on the Nasdaq Global Select Market under the symbol “INNV” since March 4, 2021.
−Removed: Prior to that, there was no public trading market for our common stock.
+Added: Our common stock is listed on the Nasdaq Global Select Market under the symbol “INNV.”
Holders of Record
−Removed: As of September 20, 2021, there were approximately two stockholders of record for our common stock.
−Removed: The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees.
+Added: As of September 12, 2022, there were approximately eight stockholders of record for our common stock.
+Added: The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by economic banks, brokers and other financial institutions.
This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.
3 unchanged sentences
Any future determination to pay dividends will be at the discretion of our Board, subject to compliance with covenants in current and future agreements governing our and our subsidiaries’ indebtedness, and will depend on our results of operations, financial condition, capital requirements and other factors that our Board may deem relevant.
−Removed: Stock Performance Graph
−Removed: The following performance graph and related information shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any registration statement or other document filed by us with the SEC, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.
−Removed: The following graph and related information shows a comparison of the change in the cumulative total return for our common stock, the Nasdaq Health Care Index, and the S&P 500 Index between March 4, 2021 (the date our common stock commenced trading on Nasdaq) through June 30, 2021.
−Removed: All values assume an initial investment of $100 and
−Removed: reinvestment of any dividends.
−Removed: The comparisons are based on historical data and are not indicative of, nor intended to forecast, the future performance of our common stock.
Recent Sales of Unregistered Securities
2 unchanged sentences
Use of Proceeds from Registered Securities
−Removed: On March 8, 2021, we completed the initial public offering (“IPO”) of our common stock pursuant to a Registration Statement on Form S-1 (File No.
−Removed: 333-252853) (“Registration Statement”), which was declared effective on March 3, 2021.
−Removed: The Company sold 18,995,901 shares of common stock, including the partial exercise of the underwriters’ option to purchase additional shares of common stock at the IPO price of $21.00 per share.
−Removed: The managing underwriters of the IPO were J.P.
−Removed: Morgan Securities LLC, Barclays Capital Inc., Goldman Sachs & Co.
−Removed: LLC and Citigroup Global Markets Inc.
−Removed: In aggregate, the shares issued in the IPO generated $373.6 million in net proceeds, which amount is net of $23.9 million in underwriters’ discounts and commissions and offering costs of $1.4 million.
−Removed: No offering expenses were paid directly or indirectly to any of our officers or directors (or their associates) or persons owning 10% or more of any class of our equity securities or to any other affiliates.
−Removed: During the year ended June 30, 2021, we used the net proceeds of the IPO, together with proceeds from our 2021 Credit Agreement, to repay all borrowings outstanding under the 2016 Credit Agreement and to fund the related prepayment fees and expenses and to satisfy an earn-out arrangement in connection with the acquisition of NewCourtland.
−Removed: There was no material change in the expected use of the net proceeds from the IPO as described in the Registration Statement.
−Removed: SELECTED FINANCIAL DATA
−Removed: The information required by Item 301 of Regulation S-K has been omitted as we have elected to early adopt the changes to Item 301 contained in SEC Release No.
+Added: On March 8, 2021, we completed the initial public offering (“IPO”) and issued and sold 18,995,901 shares of our common stock, including the partial exercise of the underwriters’ option to purchase additional shares, at a price to the public of $21.00 per share for net proceeds of approximately $373.6 million.
+Added: As of June 30, 2022, we had used all of the net proceeds from our IPO.
+Added: There was no material change in the expected use of such proceeds from that described in the final prospectus, dated March 3, 2021, filed with the SEC pursuant to Rule 424(b) relating to our Registration Statement on Form S-1 (File No.
+Added: 333-252853) (“Registration Statement”), as amended.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.